SCHEMBL6802044

SCHEMBL6802044

COc1cc(-c2cc(=O)c3ccc(O)c(O)c3o2)cc(OC)c1OC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 8/20 0.77
▸ CYP1A1 P04798 2/20 0.65
▸ CYP1B1 Q16678 2/20 0.65
▸ PABPC1 P11940 1/20 0.64
▸ ALDH1A1 P00352 5/20 0.62
▸ CYP3A4 P08684 4/20 0.62
▸ MAPT P10636 4/20 0.62
▸ HPGD P15428 3/20 0.62
▸ CYP2C9 P11712 2/20 0.62
▸ CYP2C19 P33261 2/20 0.62
▸ KDM4E B2RXH2 3/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ TP53 P04637 2/20 0.61
▸ ALOX15 P16050 2/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ HSD17B10 Q99714 2/20 0.61
▸ BRD4 O60885 1/20 0.61
▸ IKBKB O14920 1/20 0.61
▸ CYP19A1 P11511 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6613428 0.92 TERT (0.81) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6613017 0.88 TERT (0.88) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6803222 0.88 TERT (0.74) TERTCYP1A1CYP1B1PABPC1ALDH1A1
SCHEMBL1778286 0.87 TERT (1.00) TERTCYP1A1CYP1B1ALDH1A1CYP3A4
SCHEMBL6614126 0.85 TERT (1.00) TERTCYP1A1CYP1B1ALDH1A1CYP3A4
SCHEMBL6797692 0.84 CYP3A4 (0.66) TERTCYP1A1CYP1B1PABPC1ALDH1A1
SCHEMBL6612829 0.82 TERT (0.86) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6617685 0.82 CSNK2A2 (0.74) TERTALDH1A1CYP3A4MAPTHPGD
SCHEMBL6614508 0.82 TERT (0.73) TERTCYP1A1CYP1B1ALDH1A1CYP3A4
SCHEMBL6804531 0.81 TERT (0.81) TERTALDH1A1CYP3A4MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9895344-B2 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof EMORY UNIVERSITY (US) 2018-02-20 — — US disclosed
US-9895344-B2 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof EMORY UNIVERSITY (US) 2018-02-20 — — US disclosed
US-20110144196-A1 TREATING VARIOUS DISORDERS WITH 7,8-DIHYDROXYFLAVONE AND DERIVATIVES THEREOF EMORY UNIVERSITY (US) 2011-06-16 — — US disclosed
US-20110144196-A1 TREATING VARIOUS DISORDERS WITH 7,8-DIHYDROXYFLAVONE AND DERIVATIVES THEREOF EMORY UNIVERSITY (US) 2011-06-16 — — US disclosed
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CYP1A1 2499/4885CYP1B1 2221/4885
US-20110144196-A1 TREATING VARIOUS DISORDERS WITH 7,8-DIHYDROXYFLAVONE AND DERIVATIVES THEREOF NTRK2, BDNF, HTR7 TERT 3053/4885CYP1A1 923/4885CYP1B1 931/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CYP1A1 2558/4885CYP1B1 2288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback